-+ 0.00%
-+ 0.00%
-+ 0.00%

Immedica's Hyperargininemia Drug Loargys Wins Approval in Saudi Arabia

MT Newswires·11/16/2026 07:32:53
Listen to the news
07:32 AM EST, 11/16/2026 (MT Newswires) -- The Saudi Food and Drug Authority approved Sweden-based Immedica's hyperargininemia drug Loargys, or pegzilarginase. Loargys treats hyperargininemia in adults, adolescents, and children aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction, according to a Monday release.